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Abstract
Background Musculoskeletal involvement in Morquio A
syndrome (mucopolysaccharidosis IVA; MPS IVA) con-
tributes significantly to morbidity and mortality. While the
spinal manifestations of the disorder have received con-
siderable attention in the literature, there have been few
reported studies to date to guide the management of the
orthopedic problems associated with the lower and upper
extremities.
Purpose The objective was to develop recommendations
for the management of the extremities in patients with
Morquio A syndrome.
Methods A group of specialists in orthopedics, pediatrics
and genetics with experience in the management of Mor-
quio A patients convened to review and discuss current
clinical practices and to develop preliminary recommen-
dations. Evidence from the literature was retrieved. Rec-
ommendations were further refined until consensus was
reached.
Results and conclusions This present article provides a
detailed review and discussion of the lower and upper
extremity deformities in Morquio A syndrome and presents
recommendations for the assessment and treatment of these
complications. Key issues, including the importance of
early diagnosis and the implications of medical therapy, are
also addressed. The recommendations herein represent an
attempt to develop a uniform and practical approach to
managing patients with Morquio A syndrome and
improving their outcomes.
Keywords Morquio A  Mucopolysaccharidosis IVA 
MPS IVA  Lower extremity  Upper extremity
Introduction
Morquio A syndrome, or mucopolysaccharidosis IVA
(MPS IVA), is an autosomal recessive lysosomal storage
disorder caused by defective activity of N-acetyl-galacto-
samine-6-sulfatase (GALNS), an enzyme that catabolizes
the glycosaminoglycans keratan sulfate and chondroitin-6-
sulfate. Symptoms typically become apparent during the
first few months or years of life, as intracellular glycos-
aminoglycan accumulation progressively affects skeletal
structure, connective tissues and organs. Over 275 muta-
tions in the GALNS gene have been identified to date,
resulting in wide phenotypic variability [1–4]. The condi-
tion is rare, with estimates of incidence ranging from one in
76,000 live births in Northern Ireland [5] to one in 640,000
live births in Western Australia [6].
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Musculoskeletal manifestations, including short stature,
spine abnormalities, hip dysplasia, genu valgum, joint
laxity and abnormal gait, are usually among the first
symptoms to develop [7–9]. While the natural history of
Morquio A syndrome has not been well defined, muscu-
loskeletal involvement is progressive and patients typically
require multiple orthopedic interventions to prevent
deformity and to improve function [7–10]. Spinal
involvement is common and can lead to irreversible neu-
rological damage and premature death [11]. Progressive
lower extremity involvement and increasing muscle
weakness compromise mobility; consequently, many
patients require the use of walking aids or become
wheelchair-bound by adolescence [7–10]. The hands are
frequently involved and gradual declines in grip strength,
wrist stability and fine motor skills lead to significant
functional compromise [12]. Non-skeletal manifestations,
including impaired respiratory function and cardiac valve
disease, also contribute significantly to morbidity and
mortality [9, 13]. The management of Morquio A syn-
drome has typically been supportive and symptom-based,
but enzyme replacement therapy (ERT) has recently
become available [14], underscoring the importance of
early and accurate diagnosis. However, recognizing and
correctly diagnosing affected individuals, particularly those
with non-classic phenotypes, can be challenging [15, 16].
Although orthopedic care is a key component of Mor-
quio A syndrome management, guidelines for treatment
and surgical decision-making remain scarce. Recommen-
dations for the diagnosis and management of spinal
involvement in Morquio A syndrome were recently pub-
lished [11]. However, limited evidence is currently avail-
able in the literature to guide the management of the
extremities in these patients. With the aim of improving
patient outcomes, this article provides a focused and
detailed review and discussion of the orthopedic compli-
cations associated with lower and upper extremity
involvement in Morquio A syndrome, and presents rec-
ommendations for their management based on current
evidence and the experience of the authors. Additional key
issues in the management of this disorder, including the
challenges of diagnosis and the implications of medical
therapy, are also discussed.
Methods
The authors met in August 2013 to initiate the formulation
of recommendations for the orthopedic management of the
extremities in Morquio A patients. This meeting was
sponsored by BioMarin Pharmaceutical Inc. Current clin-
ical practices were reviewed and discussed; the institutions
represented by the authors are well-established referral
centers for MPS and collectively manage, have evaluated,
or completed surgeries for over 100 Morquio A patients. A
preliminary outline of recommendations was drafted dur-
ing the meeting. A review of the literature was conducted
to identify and gather relevant evidence. Due to the limited
available literature, all articles related to orthopedic man-
agement of the extremities in Morquio A syndrome,
including single case reports, were reviewed. Recommen-
dations were refined by the authors and finalized during the
development of this manuscript.
Pathophysiology
Historically viewed as a skeletal disorder, Morquio A
syndrome tends to manifest predominantly as bone dys-
plasia and short stature. While the mechanisms underlying
growth plate pathophysiology are currently not well
understood, histological studies show that articular carti-
lage is altered; specifically, keratan sulfate accumulation in
chondrocytes, poorly organized tissue structure, increased
type I collagen and reduced type II collagen, and thick
irregularly shaped collagen fibrils have been reported [17–
20]. Glycosaminoglycans influence a variety of biological
pathways, and there is evidence to suggest that keratan
sulfate accumulation modifies the expression of chondro-
genic genes [21]. Insight from other MPS animal models
suggests that glycosaminoglycan-mediated inflammation
may also play a significant role in growth plate dysfunction
[22, 23].
Diagnosis
With the recent availability of ERT for Morquio A syn-
drome, early and accurate diagnosis becomes critical for
improved patient outcomes. Because skeletal abnormalities
are common initial presenting symptoms and typically
bring a patient to medical attention, orthopedic surgeons
are uniquely positioned to ensure a timely and accurate
diagnosis of this disorder. Classic clinical signs and
symptoms include marked short stature, genu valgum,
kyphoscoliosis, pectus carinatum, abnormal gait and joint
laxity. These findings are frequently not evident until the
third or fourth year of life. Typically, the earliest muscu-
loskeletal manifestation is the characteristic thoracolumbar
gibbus, which is often evident in the first 6 months.
Familiarity with the radiographic manifestations of dysos-
tosis multiplex aids the recognition of a possible MPS
disorder [24]. Classic radiographic findings include
abnormally shaped vertebral bodies with anterior beaking,
posterior scalloping, platyspondyly, dens hypoplasia, short
ulna, steep radius, short and broad metacarpals with
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proximal rounding, delayed carpal bone maturation, roun-
ded iliac wings, inferiorly tapered ilia, and hypoplastic
epiphyses [24–26]. In practice, however, there is wide
variability in presentation, leading to the potential for a
delayed or missed diagnosis. In patients with non-classic
phenotypes, the radiographic manifestations associated
with dysostosis multiplex may be subtle or absent, and
epiphyseal and/or vertebral changes may resemble those of
other skeletal disorders/dysplasias [25]. Recent case series
that highlight the challenges of diagnosing Morquio A
syndrome suggest that MPS should be considered in sus-
pected cases of multiple epiphyseal dysplasia, spondylo-
epiphyseal dysplasia and bilateral Perthes-like disease [15,
16]. Consideration of the overall clinical picture is also
important, as non-skeletal manifestations such as corneal
clouding, umbilical hernias and cardiac valve disease can
yield vital clues for achieving a correct diagnosis. Once
clinical suspicion of an MPS disorder has been established,
the patient should be referred to a geneticist for biochem-
ical testing. Diagnostic enzyme testing is required for a
definitive diagnosis of Morquio A syndrome, since urinary
glycosaminoglycan analysis alone can be misleading [15,
16, 26]. Significantly reduced or absent GALNS enzyme
activity in isolated leukocytes or cultured skin fibroblasts is
diagnostic of Morquio A syndrome; however, additional
enzyme analyses to rule out Morquio B syndrome and
multiple sulfatase deficiency are highly recommended for
definitive diagnosis [26]. Molecular analysis can also be
useful in confirming a diagnosis of Morquio A syndrome if
two known causative mutations can be identified [26]. A
diagnostic testing algorithm has recently been published to
streamline this complex process [26].
Growth
Patients with ‘‘classic’’ Morquio A syndrome generally have
very short stature. Although growth is typically normal
during infancy, growth velocity usually starts to decline after
the age of 1 year [27]. By the age of 3 years, growth delay is
evident. As a result, standard atlases cannot be used to stage
growth in these patients. Patients with ‘‘non-classic’’ Mor-
quio A syndrome often present with normal stature that fails
to stay within normal limits during the pre-adolescent growth
spurt [15]. Consequently, determination of bone age and
growth potential is difficult and must be considered when
formulating treatment plans. Growth charts for Morquio A
syndrome have been developed and can offer some guidance
in this regard [27]. Familiarity with the phenotypic vari-
ability in Morquio A syndrome is required for interpretation
of these growth charts. While patients with a ‘‘classic’’
phenotype follow a generally predictable growth pattern,
others may demonstrate wide variability.
Lower extremity involvement
Hip dysplasia and subluxation
Morquio A patients typically present with abnormal ossi-
fication of the proximal femoral epiphysis, mildly sublux-
ated hips with a shallow and small acetabulum, and
femoral neck valgus (Fig. 1). Initial development of the hip
is broadly normal, but in severe cases, changes may
develop as early as the second year of life. Progressive
collapse and flattening of the ossific nucleus of the proxi-
mal femoral epiphyses are observed over time. Anterior
superior deficiency of the acetabulum exists with a general
appearance of a shallow, dysplastic acetabulum. Femoral
head coverage progressively decreases with age, resulting
in progressive subluxation of the hips. The native acetab-
ulum becomes progressively shallower and is eventually
lost with development of a pseudo-acetabulum. Knee
deformity (genu valgum) may accelerate these hip defor-
mities. Left untreated, hip subluxation predisposes patients
to degenerative arthritis.
Fig. 1 Progression of hip deformities in Morquio A syndrome. a 3-
year-old female with dysplastic proximal femoral epiphyses and
dysplastic acetabulum. Subluxation, as evident by the break in
Shenton’s line, is present at this early age. b A similar deformity is
found in an untreated 8-year-old with worsening epiphyseal flattening
and incongruent acetabulum
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Genu valgum
The knee is the most commonly affected lower extremity
joint in Morquio A syndrome [7–9]. Genu valgum typically
progresses once ambulation commences, and usually
becomes severe enough to warrant surgery (Fig. 2). Laxity
of the collateral ligaments aggravates the deformity. The
proximal tibia appears to contribute more deformity than
the distal femur. There may also be procurvatum of the
distal femur with recurvatum of the proximal tibia. Ar-
thrograms or magnetic resonance imaging (MRI) of the
knees in these patients show the proximal lateral portion of
the tibia to be unossified and the fibula to be short, and can
offer clarity as to the bony or cartilaginous nature of the
deformity [8]. Progressive collapse and fragmentation of
the ossific portion of the femoral and tibial epiphysis
resembles that of the hip.
Ankle valgus and foot deformities
The ankles of Morquio A patients are typically in valgus
with wedging of the distal tibial epiphysis and shortening
of the fibula. The severity of the ankle valgus is variable
and may progressively worsen over time. There may be
hindfoot valgus, some degree of equinus in the hindfoot,
and adductus in the forefoot. There is some degree of
supination with first metatarsal head prominence dorsally.
On lateral views, tarsal bones are irregular and the talus
appears plantarflexed.
Abnormal gait
Reduced speed, cadence and stride length are primary gait
abnormalities associated with Morquio A syndrome [28].
Lower extremity malalignment, muscle weakness and joint
laxity contribute to the pathological gait pattern. Knee
valgus causes the ground reaction force to be shifted lat-
erally, which forces the knee into further valgus (Fig. 3).
The extensor mechanism may subluxate laterally, resulting
in reduced extensor mechanism moment arm. In severe
cases, the ground reaction force moves behind the center of
the rotation, necessitating quadriceps activity throughout
stance phase, and may cause a flexion contracture of the
knee. As individuals develop progressive genu valgum and
subluxation of the extensor mechanism, there is a tendency
for the tibia to follow into external rotation. This results in
further reduction in power generation at the ankle. Even-
tually, the mechanics become so abnormal and power
generation so poor that individuals cease ambulating.
Upper extremity involvement
Bony anomalies
Characteristic radiographic findings in the hands and distal
forearms of individuals with Morquio A syndrome (Fig. 4)
include a short ulna, ulnar deviation of the radial epiphysis,
and delayed maturation of the carpal bones; the scaphoid
Fig. 2 Genu valgum is common in Morquio A syndrome and often
requires surgical correction. Guided growth using the tension band
plate technique can be effective for genu valgum correction in
younger patients with adequate growth potential. A patient who
underwent surgical intervention for genu valgum a at age 9 years, b at
age 10 years, c at age 12 years (slight over-correction, tension band
plates removed) and d at age 16 years (skeletally mature)
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may not be radiographically present [25, 29]. Metacarpals
may be short and the proximal ends of the second through
fifth metacarpals are typically rounded (or pointed) [25,
29].
Wrist hypermobility and reduced strength
Clinical examination of the hands of Morquio A patients
usually reveals a hypermobility of the wrist joint with a
characteristic ulnar deviation (Fig. 5) that affects the active
and passive joint range of motion (ROM). Patients typi-
cally show significant differences in active and passive
ROM at the wrist joint, reflecting the loss of stability at this
joint [12]. It is unclear if the hypermobility is due to
abnormalities of the bone, ligaments, and/or muscles. A
likely result of this hypermobility is the reduced strength of
the wrist, metacarpophalangeal, and proximal interpha-
langeal joints. Patients typically show a pronounced
decrease in grip and pinch strength and have difficulties
performing day-to-day tasks requiring strength such as
pouring from a bottle, carrying objects, and using a fork
and knife [12]. In contrast, patients usually do not show
significant impairment in performing tasks that involve
pressing buttons or typing, such as using computers or
mobile devices, over short periods [12].
Diagnostic and monitoring tools
Lower extremity
Physical examination
Physical examination of the lower extremities should
include evaluation of overall alignment, joint ROM, and
gait pattern. Alignment of the knees, ankles and feet typi-
cally reveals valgus deformities. Hip ROM should include
prone internal and external rotation, as well as a Thomas
test for hip flexion contractures. Knee ROM may reveal
flexion contractures. Assessment of the intermalleolar
distance (both standing and supine) is a good method of
clinically assessing genu valgum. Ligamentous laxity,
Fig. 4 Hand and wrist changes in Morquio A syndrome. Carpal
ossification delay, short and broad metacarpals, metacarpal rounding,
and a short ulna are evident in the radiograph of an 8-1/2-year old
female.
Fig. 5 Hypermobility and ulnar deviation of the wrist joint are
characteristic features of Morquio A syndrome
Fig. 3 Malalignment of the knee joint alters the biomechanics of gait
in patients with Morquio A syndrome. Knee valgus causes the ground
reaction force to be shifted laterally, which forces the knee into
further valgus. The degree of genu valgum may be estimated by the
quadriceps angle, or Q angle (the angle formed by a line drawn from
the anterior superior iliac spine through the center of the patella and a
line drawn from the center of the patella to the center of the tibial
tubercle). Multiple anatomical factors contribute to the magnitude of
the Q angle, including hip rotation, tibial torsion and foot position
J Child Orthop (2014) 8:295–304 299
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particularly of the medial collateral ligament and cruciates,
is common. Gait pattern, as discussed previously, results
from progressive knee extensor dysfunction. Myelopathic
gait (broad based gait with decreased cadence) may
develop with spinal cord compression. Further detailed
neurological examination including evaluation of strength,
sensation (including vibratory discrimination) and reflexes
should also be performed every 6 months for the first
5 years of life, and then yearly thereafter.
Imaging
Radiography is the standard imaging modality for evalu-
ating lower limb alignment. Pelvis and standing full-length
anteroposterior radiographs should be obtained at the time
of diagnosis. Radiographic analyses should include
mechanical axis zone measurements as defined by Stevens
[30], knee and ankle measurements, including the tibio-
femoral angle (TFA), mechanical lateral distal femoral
angle (LDFA) and medial proximal tibial angle (MPTA),
as described by Paley et al. [31], and pelvis measurements
including neck shaft angle, femoral head coverage, and
acetabular index. Follow-up radiographic studies should be
performed on patients who show signs of progressive hip
dysplasia, genu valgum or gait abnormalities on physical
examination.
Although radiographs are the mainstay for assessing and
monitoring lower extremity bone involvement, they are
limited in their utility for preoperative planning. Two-
dimensional computed tomography (CT), which provides
detailed information on bone structure and allows precise
determination of bony dimensions, is recommended for
pre-operative decision-making and planning for acetabular
reconstructive procedures [32]. CT studies are also helpful
for evaluating static torsional alignment. Progressive
fragmentation and collapse of the osseous structures can
lead to false assumptions regarding the anatomy around
joints. Arthrography or MRI can give a more accurate
picture of the non-ossified structures and the articular
surfaces. The cartilaginous part of the epiphysis is often not
as deformed as would be expected by the plain radiographs.
Gait analysis
Instrumented gait analysis can be a useful tool for pre-
operative planning and for objectively assessing surgical
outcomes. It enables identification of the factors that con-
tribute to impaired gait, including rotational malalignment
that cannot be determined from weight-bearing standing
radiographs. Torsional and angulatory malalignments may
be magnified during gait, and as such, the dynamic nature
of gait analysis provides additional information to static
examinations such as MRI or CT. However, the acquisition
and analysis of the kinematic and kinetic data are time-
consuming and currently limit the utility of gait analysis as
a routine functional assessment and monitoring tool. As
gait analysis is not available at many institutions, referral
of a patient to a specialty center should be considered when
gait studies are deemed valuable.
The group consensus is that it is advisable to correct
deformity (particularly around the knee) early. In young
children (\5 years of age), gait deviations will be minimal
and gait analysis is probably not necessary. Older children
may either present with severe gait disturbance or may
have developed recurrent deformity. In such cases, gait
analysis serves several purposes. Many children can have
deformity at the hip, knee and ankle levels. In addition,
deformity occurs in the sagittal, coronal and transverse
planes. Interpreting such complex deformity by simple
observation is difficult. Gait analysis not only allows
kinematic data to be examined, but also kinetic data.
Appreciation of power generation and moment arms at the
joints is important, since injudicious surgical intervention
may render more severely involved children immobile. The
aim of surgery is to maintain the ground reaction force as
close to the center of rotation of the joint as possible, and
this may involve correction of deformity at several levels
and in several planes. Pre-operative assessment of this is
only possible with instrumented gait analysis. Equally
important is the objective measurement of post-operative
results.
Upper extremity
ROM and strength
Regular assessments of ROM and strength provide insight
into the degree and progression of functional impairment of
the hands. Both active and passive ROM of the wrists and
digits should be determined using a goniometer. Grip
strength should be assessed using a dynamometer, and
pinch strength should be measured using a pinch meter.
ROM of the elbows and shoulders may also be examined if
deemed useful.
Functional assessments
Assessments of the activity limitations of Morquio A
patients should be regularly conducted. The Functional
Dexterity Test (FDT), a validated and timed pegboard test
that is easy to administer, assesses the ability to perform
functional daily tasks that require a three-jaw chuck pre-
hension pattern (also referred to as the palmar pinch, pencil
pinch, or tripod grip), such as writing and buttoning [33,
34]. Patient self-report questionnaires designed to evaluate
the impact of hand function on health-related quality of life
300 J Child Orthop (2014) 8:295–304
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are also recommended to guide treatment strategies. One
such tool that is widely used for multiple hand and wrist
conditions is the Disabilities of the Arm, Shoulder and
Hand (DASH) questionnaire [35, 36]. Disease-specific
outcome tools are likely to yield more useful information.
A questionnaire has recently been developed and used by
hand surgeons and therapists to evaluate limitations in
activities of daily living in Morquio A patients [12].
Recommended assessments
Once diagnosed, Morquio A patients should undergo reg-
ular assessments to evaluate the severity and progression of
lower and upper extremity involvement. Recommended
assessments are presented in Table 1. Ideally, the fre-
quency of clinic visits and assessments should be tailored
to meet the individual needs of each patient.
Interventions
Lower extremity
Lower extremity alignment and hip joint correction are
among the most common interventions for this patient
population [7]. It is generally assumed that many patients
with Morquio A syndrome will develop arthrosis requiring
total joint arthroplasty of the knees or hips. However, no
studies of the true natural history of this disease currently
exist. Consequently, treatment is directed at the mainte-
nance of lower extremity alignment and joint congruity.
Care should be taken to not surgically alter the anatomy in
these patients in such a way that will complicate the ulti-
mate need for hip or knee replacement.
Hips
Hip reconstruction can be helpful in treating and postponing
hip pain. The reconstruction may include either acetabular
osteotomy or femoral osteotomy for less severe deformities
[37], but a combination of acetabular and femoral osteoto-
mies is typically required to correct hip subluxation in
patients with classical disease [10]. Hip reconstruction can
be challenging in Morquio A patients due to a shallow ace-
tabulum. Augmentation of acetabular bone stock and cus-
tomized implants are often required. As hip replacement
appears to be inevitable in these patients, the goals of pedi-
atric hip reconstruction should include improving the lon-
gevity of the native hip while respecting the anatomy of the
hip in order to reduce the challenges of future hip replace-
ment procedures. As some early experience with the Pem-
berton, Salter or femoral varus derotation osteotomies alone
resulted in reoperation for failure to contain the femoral
head, a recent report [10] advocates the use of large shelf
arthroplasties which have resulted in better success in
maintaining containment than Salter or Pemberton osteoto-
mies [10, 38]. Cortical grafts from the inner table of the ilium
were used, providing large grafts with a concave cortical
surface to ensure improvement of the overall coverage of the
acetabulum. Concomitant femoral varus de-rotational oste-
otomies may be needed to improve the neck shaft angle
closer to 1258 in these patients. In individuals who are bor-
derline ambulant prior to surgery, it may be difficult to regain
their previous level of mobility after such surgery. It is
critical not to overcorrect with varus, as these patients tend to
develop a waddling gait due to abductor shortening. Over-
correction with varus also functionally increases hip
adduction, thus emphasizing their genu valgum, which
compromises their walking ability further [10, 28]. Total hip
arthroplasty may be an option for young adult patients with
pain-limiting hip disease that cannot be repaired using tra-
ditional reconstructive techniques [39–42].
Knees
Guided growth appears to be a reliable and effective
technique for correcting genu valgum in young patients
with adequate growth potential (Fig. 2). The principle of
guided growth relies upon temporary growth modulation of
Table 1 Recommended assessments for evaluating and monitoring
lower and upper extremity involvement in Morquio A syndrome
Assessment At
diagnosis
Annually As
clinically
indicated
Lower extremities
Physical examination X X
AP pelvis radiographa X X X
AP standing radiographs X X
2-D computed tomography
(CT) for rotational
alignment
X
2-D CT for pre-operative
planning
X
MRI X
Arthrography X
Formal gait analysis X
Upper extremities
Hand and wrist radiographs X
Joint range of motion X X
Grip strength X X
Pinch strength X X
Functional assessments X X
a AP pelvis radiographs should be obtained annually until skeletal
maturity, and then as clinically indicated
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the physis using a tension band plate [43]. Typically, both
the proximal tibial and distal femoral physes are addressed;
however, if the deformity is confined to only one of these
sites, then the procedure is performed in isolation as indi-
cated. While this surgery may be performed as an outpa-
tient procedure, an overnight stay is recommended for
patients with this complex disorder.
Because growth is retarded in patients with Morquio A
syndrome, correction takes longer than typically expected,
particularly if the deformity is significant. Leaving the
plates in situ for 2–3 years may be necessary, but does not
appear to be detrimental. There have been no reported
cases of permanent growth arrest associated with this
procedure. Treatment should be initiated as soon as the
deformity is observed, which may necessitate surgery in
patients as young as 4 years of age. Repeated interventions
should be anticipated as these children grow. It is currently
unknown whether this technique has the ability to correct
the most severe deformities. Although there may be con-
cerns regarding whether the hypoplastic bone in these
patients will support the screws inserted during plate
hemiepiphysiodesis, this does not appear to be a problem.
In situations of severe deformity or limited remaining
growth potential, growth modulation techniques may not be
effective. In these circumstances, the only surgical solution
is an osteotomy. Osteotomy may be performed acutely and
the knee subsequently stabilized with plates and screws.
Alternatively, gradual correction using a uniplanar or mul-
tiplanar external fixation frame may be employed. Both
acute and gradual corrections are associated with potential
complications. Acute correction risks injury to the common
peroneal nerve. Bones are generally small and osteopenic
[44], and subsequent fixation with implants (plates and
screws) may be difficult. Recovery from acute operations can
be prolonged, and in patients at risk of losing the ability to
walk prior to surgery, it is possible that they may not return to
their preoperative functional level.
One of the implications of improved management of the
knee deformity is that patients will continue to walk and
their hips and knees may then become increasingly
symptomatic. If so, consideration for joint arthroplasty may
be necessary. Total knee arthroplasty should be considered
for patients with advanced arthrosis [45, 46]. Very few
reports exist in the literature regarding arthroplasty in
severely involved Morquio A patients. Custom made
implants should be anticipated.
Ankle and foot
Ankle valgus and foot deformities can generally be managed
by orthotics. Surgical options to correct ankle valgus include
guided growth for smaller deformities in young children with
adequate growth potential (via screw hemiepiphysiodesis)
and osteotomy for larger deformities in older patients [10].
However, ankle valgus may recur. Surgical correction of the
foot deformity is seldom required, but orthotics may help in a
symptomatic equinovalgus foot.
Upper extremity
Treatment for upper extremity manifestations should be
guided by the functional status of the patient. Non-opera-
tive interventions include external splints to stabilize the
wrist and to add strength, but children typically do not
tolerate wearing them as they are usually bulky and inhibit
function. The current surgical options for treating upper
limb manifestations of Morquio A syndrome include per-
manent stabilization (for example, wrist fusion or partial
fusion). Complete wrist fusion may not be optimal, as these
patients rely on some residual wrist movement that is
essential for key functions such as bed to wheelchair
transfer. Soft tissue stabilization or partial fusions might
present better surgical options in the future for treating
these patients. Functional assessments should be performed
on a regular basis to monitor changes in activity limitations
and upper limb functioning over time.
Peri-operative management and anesthetic
considerations
Morquio A patients are at high risk of anesthesia-related
morbidity and mortality due to cervical instability and mye-
lopathy, compromised respiratory function and cardiac
abnormalities [11, 47, 48]. Thorough pre-operative ear, nose
and throat (ENT), pulmonary, cardiac, and radiological (cer-
vical spine) assessments should be performed prior to elective
surgery. Morquio A patients should be managed by experi-
enced anesthesiologists familiar with MPS disorders. Correct
positioning of the patient is critical and flexion and extension
movements of the neck should be minimized. The use of
continuous electrophysiological monitoring (somatosensory
and motor evoked potentials) is recommended due to the
cervical instability and high risk of cord compression [11, 47,
48]. Intubation and ventilation difficulties as well as the need
for emergency tracheostomy should be anticipated, and per-
sonnel experienced in managing complex airways and diffi-
cult airway equipment should be readily available [11, 47, 48].
Whenever possible, multiple surgeries should be combined to
minimize anesthetic frequency.
Future perspectives
Currently, it is unknown if the interventions described
herein will result in long-term improvement of the
302 J Child Orthop (2014) 8:295–304
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functional status of patients, or if the need for total joint
replacement is inevitable. More studies to assess the long-
term impact of surgical intervention will be required,
underscoring the need to develop validated Morquio A
syndrome-specific patient-reported outcome tools that will
allow surgeons to quantify preoperative and postoperative
functional status and to guide treatment strategies.
Research is currently underway to develop validated out-
come tools to assess upper and lower extremity functioning
in Morquio A patients [12, 49]. Continuing advances in
surgical techniques and devices will likely result in
improved outcomes.
ERT for Morquio A syndrome will create new chal-
lenges for the orthopedic management of these patients.
With potentially prolonged life expectancy, patients will
likely require more frequent and more extensive orthopedic
intervention. Enhanced endurance and mobility may
encourage patients to adopt a more active lifestyle, and
changes in patient expectations will likely impact ortho-
pedic treatment strategies. Patient quality of life will be
expected to assume a greater role in outcome studies.
The impact of ERT on Morquio A syndrome growth
plate pathology remains to be seen. It has been demon-
strated that the therapeutic enzyme penetrates poorly vas-
cularized tissues, including growth plate cartilage in vivo
[21]. Elucidation of the mechanisms that cause Morquio A
syndrome pathophysiology may provide insight into opti-
mal modes of therapy. Gene therapy may represent a
promising therapeutic option for the future [50].
Conclusions
The goals of orthopedic management of Morquio A
patients are to minimize disability and to optimize func-
tional status. Maintaining normal alignment of the lower
limbs is crucial for preserving ambulatory ability.
Achieving optimal hand function is important for per-
forming activities of daily living. Standardized patient-
reported outcome measures should be developed to assess
the impact of orthopedic interventions and to enhance
patient care. The availability of ERT underscores the
importance of early diagnosis and timely intervention.
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